Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Outcome in juvenile dermatomyositis.

Vaidehi Chowdhary1, Anupam Wakhlu, Amita Agarwal

  • 1Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Rae Barielly Road, Lucknow. rnmisra@sgpgi.ac.in

Indian Pediatrics
|November 13, 2002
PubMed
Summary

Early recognition and aggressive treatment of juvenile dermatomyositis (JDM) are crucial for improving patient outcomes. This study highlights key clinical features, treatment responses, and complications in pediatric JDM cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Features and Outcome of Neuropsychiatric Manifestations in Juvenile Onset Systemic Lupus Erythematosus.

Indian journal of pediatrics·2026
Same author

Short-Term Effectiveness of Sulfasalazine and Tofacitinib in NSAID-Refractory Reactive Arthritis: An Observational Study.

International journal of rheumatic diseases·2025
Same author

2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same author

2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis.

Arthritis care & research·2025
Same author

Yoga as an adjunctive therapy for rheumatoid arthritis.

The Cochrane database of systematic reviews·2025
Same author

Serious infections and tuberculosis adversely impact outcomes of juvenile onset systemic lupus erythematosus in India.

Lupus·2024

Area of Science:

  • Pediatric Rheumatology
  • Immunology

Background:

  • Juvenile dermatomyositis (JDM) is a rare autoimmune disease affecting children.
  • Understanding its clinical spectrum, treatment, and complications is vital for effective management.

Purpose of the Study:

  • To analyze the clinical features, outcomes, and complications of juvenile dermatomyositis.
  • To evaluate treatment responses and identify factors influencing prognosis in JDM patients.

Main Methods:

  • Retrospective analysis of case records from a tertiary care hospital.
  • Inclusion of 19 patients diagnosed with juvenile dermatomyositis over an 11-year period.
  • Review of clinical manifestations, diagnostic delays, treatment regimens, and patient outcomes.

Main Results:

Related Experiment Videos

  • Proximal muscle weakness, heliotrope rash, and Gottron's rash were common presenting features.
  • Complications included calcinosis, contractures, tuberculosis, and pyogenic infections.
  • Significant rates of complete and partial remission were observed with prednisolone and methotrexate treatment.

Conclusions:

  • Juvenile dermatomyositis requires prompt diagnosis and aggressive therapeutic strategies.
  • Early intervention can lead to improved remission rates and reduced long-term complications.
  • Multidisciplinary care is essential for managing the diverse clinical manifestations of JDM.